A2M and prostate carcinoma: In addition, α2M was reported to bind to the GRP78 receptor on the surface of the cell membrane, activating the IGFR and mTOR signaling pathways in prostate cancer, suggesting the involvement of the AKT/mTOR pathway in α2M-mediated cancer development [42, 43].